Aspira Pathlab & Diagnostics L Share Price
Aspira Pathlab & Diagnostics L Share Price Today
As of 5 Jul 2026, Aspira Pathlab & Diagnostics L share price is ₹128.90. The stock opened at ₹128.90, compared to its previous close of ₹131.50. During today's trading session, Aspira Pathlab & Diagnostics L share price moved in the range of ₹128.90 to ₹128.90, with an average price of ₹128.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹49.00 and a high of ₹135.88.
Aspira Pathlab & Diagnostics L Returns Calculator
Aspira Pathlab & Diagnostics L Shareholder Returns
Aspira Pathlab & Diagnostics L Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Apollo Hospitals | 1,25,057.00 | 62.45 | 13.20 | 20.48% | 0.32 | 17.27% | 692.92 | 0.23% | 0.70 | 103.81 |
| Max Healthcare | 1,09,728.00 | 76.08 | 10.21 | 13.42% | 0.09 | 12.97% | 91.86 | 0.18% | 0.28 | 7.37 |
| Fortis Healthcare | 73,604.60 | 69.15 | 7.44 | 10.53% | 0.23 | 12.56% | 122.24 | 0.10% | 0.16 | 3.05 |
| Aster DM Healthcare | 40,962.60 | 95.95 | 9.69 | 8.48% | 0.31 | 10.10% | 83.23 | 0.38% | 0.46 | 5.20 |
| Narayana Hrudayalaya | 40,570.70 | 50.34 | 8.94 | 17.76% | 0.76 | 11.42% | 127.10 | 0.23% | 0.85 | 24.77 |
| Global Health | 36,176.70 | 65.28 | 9.13 | 14.05% | 0.06 | 15.26% | 149.24 | 0.04% | 0.77 | 18.46 |
| KRISHNA INST OF MED SCI L | 35,097.80 | 145.08 | 9.37 | 10.74% | 0.63 | 7.99% | 93.54 | 0.00% | 0.46 | 6.52 |
| Dr. Lal Path Labs | 27,697.10 | 54.33 | 11.04 | 20.13% | 0.07 | 25.56% | 8.90 | 1.56% | 1.01 | 30.45 |
| Syngene International | 17,755.40 | 56.03 | 3.67 | 7.76% | 0.04 | 9.67% | 116.55 | 0.28% | 0.67 | 7.58 |
| Poly Medicure | 17,614.20 | 54.92 | 5.67 | 10.37% | 0.08 | 12.71% | 301.18 | 0.20% | 0.53 | 33.15 |
Aspira Pathlab & Diagnostics L Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Revenue | ₹22.00 | ₹13.20 |
| Other Income | ₹0.39 | ₹0.42 |
| Total Revenue | ₹22.39 | ₹13.63 |
| Total Expenses | ₹20.32 | ₹16.30 |
| Profit Before Tax | ₹2.02 | -₹2.67 |
| Tax | ₹0.00 | ₹0.00 |
| Profit After Tax | ₹2.02 | -₹2.67 |
| EPS - Basic | ₹1.97 | -₹2.60 |
| EPS - Diluted | ₹1.97 | -₹2.60 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Profit before tax | ₹2.02 | -₹2.67 |
| Income before WC changes | ₹3.80 | -₹0.90 |
| Change in Assets | -₹2.29 | ₹1.45 |
| Change in Liabilities | ₹0.32 | ₹0.51 |
| Change in WC | -₹1.97 | ₹1.96 |
| Cash flow from Operations | ₹1.83 | ₹1.05 |
| Cash flow from Investing | ₹0.12 | ₹0.14 |
| Cash flow from Financing | -₹0.99 | -₹0.95 |
| Total Cash Flow | ₹0.95 | ₹0.24 |
| Cash (Start of the year) | ₹0.80 | ₹0.57 |
| Cash (End of the year) | ₹1.75 | ₹0.80 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 |
|---|---|---|
| Non-Current Assets | ₹12.10 | ₹10.35 |
| Current Assets | ₹5.36 | ₹4.36 |
| Total Assets | ₹17.46 | ₹14.71 |
| Current Liabilities | ₹2.37 | ₹2.07 |
| Net Current Asset | ₹2.99 | ₹2.28 |
| Non-Current Liabilities | ₹2.92 | ₹2.50 |
| Equity Capital | ₹12.17 | ₹10.14 |
| Total Equity & Liabilities | ₹17.46 | ₹14.71 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹22.00 | ₹13.20 | ₹14.46 | ₹19.54 |
| Other Income | ₹0.39 | ₹0.42 | ₹0.32 | ₹0.09 |
| Total Revenue | ₹22.39 | ₹13.63 | ₹14.78 | ₹19.64 |
| Total Expenses | ₹20.32 | ₹16.30 | ₹14.87 | ₹15.18 |
| Profit Before Tax | ₹2.07 | -₹2.67 | -₹0.09 | ₹4.46 |
| Tax | ₹0.00 | ₹0.00 | ₹0.00 | ₹0.00 |
| Profit After Tax | ₹2.07 | -₹2.67 | -₹0.09 | ₹4.46 |
| EPS - Basic | ₹2.01 | -₹2.60 | -₹0.09 | ₹4.33 |
| EPS - Diluted | ₹2.01 | -₹2.60 | -₹0.09 | ₹4.33 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | ₹2.07 | -₹2.67 | -₹0.09 | ₹4.46 |
| Income before WC changes | ₹3.85 | -₹0.90 | ₹1.71 | ₹6.86 |
| Change in Assets | -₹2.29 | ₹1.45 | -₹1.59 | -₹4.87 |
| Change in Liabilities | ₹0.32 | ₹0.51 | -₹0.14 | ₹0.05 |
| Change in WC | -₹1.97 | ₹1.96 | -₹1.73 | -₹4.83 |
| Cash flow from Operations | ₹1.88 | ₹1.05 | -₹0.01 | ₹2.03 |
| Cash flow from Investing | ₹0.07 | ₹0.14 | ₹0.16 | -₹0.51 |
| Cash flow from Financing | -₹0.99 | -₹0.95 | -₹0.94 | -₹1.35 |
| Total Cash Flow | ₹0.95 | ₹0.24 | -₹0.79 | ₹0.17 |
| Cash (Start of the year) | ₹0.80 | ₹0.57 | ₹1.35 | ₹1.19 |
| Cash (End of the year) | ₹1.75 | ₹0.80 | ₹0.57 | ₹1.35 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹12.15 | ₹10.35 | ₹11.49 | ₹10.99 |
| Current Assets | ₹5.36 | ₹4.36 | ₹5.86 | ₹7.14 |
| Total Assets | ₹17.51 | ₹14.71 | ₹17.34 | ₹18.14 |
| Current Liabilities | ₹2.37 | ₹2.07 | ₹1.58 | ₹1.79 |
| Net Current Asset | ₹2.99 | ₹2.28 | ₹4.27 | ₹5.36 |
| Non-Current Liabilities | ₹2.92 | ₹2.50 | ₹3.01 | ₹3.56 |
| Equity Capital | ₹12.22 | ₹10.14 | ₹12.75 | ₹12.79 |
| Total Equity & Liabilities | ₹17.51 | ₹14.71 | ₹17.34 | ₹18.14 |
About Aspira Pathlab & Diagnostics L
Aspira Pathlab & Diagnostics Limited is an India-based company, which is engaged in the business of running, owning, managing, and administering Diagnostics Centers. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at diagnostic centers in Mumbai. The Company carries out pathological investigations in various branches, including biochemistry, hematology, histopathology, microbiology, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The Company's tests include pathology test, sonography, x-ray, and radiology. Its pathology tests include Influenza (Flu) Panel with H3N2, Blood chromosome analysis, Filmarray multiplex PCR(BIOFIRE) Pneumonia Panel Plus, Polycystic Ovarian Syndrome (PCOS) 2, Typhoid PCR, Dengue-Chikungunya-Malaria multiplex PCR, Vitamin And TSH, Fever screening profile-2, and others.
Aspira Pathlab & Diagnostics L Financial Highlights
- Revenue: Aspira Pathlab & Diagnostics L reported revenue of ₹22.39 crore in FY25 vs ₹13.62 crore in FY24. It showed an increase of 64.39% on a yearly basis.
- Operating Profit: Aspira Pathlab & Diagnostics L reported an operating profit of ₹2.02 crore in FY25 vs ₹2.67 crore in FY24. It showed an increase of 175.66% on a year-on-year basis.
- Net Profit: Aspira Pathlab & Diagnostics L reported a net profit of ₹2.02 crore in FY25 vs ₹2.67 crore in FY24. It showed an increase of 175.66% on a yearly basis.
Aspira Pathlab & Diagnostics L Quarterly Result Highlights
- Aspira Pathlab & Diagnostics L reported revenue of ₹5.36 crore in Jun 2025, compared with ₹5.91 crore in Mar 2025, representing a decrease of 9.31% on a quarter-on-quarter (QoQ) basis.
- Aspira Pathlab & Diagnostics L reported an operating profit of ₹0.42 crore in Jun 2025, compared with ₹0.68 crore in Mar 2025, representing a decrease of 38.24% on a quarter-on-quarter (QoQ) basis.
- Aspira Pathlab & Diagnostics L reported a profit of ₹0.42 crore in Jun 2025, compared with ₹0.68 crore in Mar 2025, reflecting a decrease of 38.24% on a QoQ basis.
- The earnings per share (EPS) of Aspira Pathlab & Diagnostics L stood at ₹1.97 during Jun 2025.
Similar Stocks
FAQs on Aspira Pathlab & Diagnostics L Share Price
What is Aspira Pathlab & Diagnostics L share price today?
Aspira Pathlab & Diagnostics L share price is ₹128.90 as on 03 Jul, 2026, 14:15 IST.
How has the Aspira Pathlab & Diagnostics L share price performed in the past?
In the last 1 year, Aspira Pathlab & Diagnostics L delivered a return of 131.34%. The Aspira Pathlab & Diagnostics L share price hit a high of ₹135.88 and low of ₹49.00.
How much is the Mutual Fund shareholding in Aspira Pathlab & Diagnostics L shares?
The Mutual Fund Shareholding in Aspira Pathlab & Diagnostics L was 0.00% at the end of Mar 2026.
What is the the 52-week high and low of Aspira Pathlab & Diagnostics L shares ?
The 52-week high and low of Aspira Pathlab & Diagnostics L share is ₹135.88 and ₹49.00 as of 03 Jul, 2026.
What is the market cap of Aspira Pathlab & Diagnostics L?
The market capitalisation of Aspira Pathlab & Diagnostics L is ₹135.35 Crores as on 03 Jul, 2026.
What are the stock symbols of Aspira Pathlab & Diagnostics L?
The stock symbol of Aspira Pathlab & Diagnostics L is 540788 on the BSE, and the ISIN is INE500C01017.
What was yesterday's closing price for Aspira Pathlab & Diagnostics L shares ?
Aspira Pathlab & Diagnostics L shares closed yesterday at ₹131.50 on BSE
How to buy Aspira Pathlab & Diagnostics L shares?
To buy Aspira Pathlab & Diagnostics L shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Aspira Pathlab & Diagnostics L shares on Holidays?
No, shares of Aspira Pathlab & Diagnostics L or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Aspira Pathlab & Diagnostics L shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Aspira Pathlab & Diagnostics L?
The PE and PB ratio of Aspira Pathlab & Diagnostics L is 56.44 and 18.7 respectively, as on 03 Jul, 2026, 14:15 IST.